SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-212993
Filing Date
2019-08-05
Accepted
2019-08-05 16:19:06
Documents
70
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d710696d10q.htm 10-Q 481142
2 EX-10.1 d710696dex101.htm EX-10.1 35924
3 EX-31.1 d710696dex311.htm EX-31.1 6350
4 EX-31.2 d710696dex312.htm EX-31.2 6398
5 EX-32.1 d710696dex321.htm EX-32.1 4199
6 EX-32.2 d710696dex322.htm EX-32.2 4501
13 GRAPHIC g710696g38x60.jpg GRAPHIC 8888
  Complete submission text file 0001193125-19-212993.txt   5457922

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ccxi-20190630.xml EX-101.INS 1569038
8 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20190630.xsd EX-101.SCH 42994
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20190630_cal.xml EX-101.CAL 40636
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20190630_def.xml EX-101.DEF 172454
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20190630_lab.xml EX-101.LAB 373480
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20190630_pre.xml EX-101.PRE 293695
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 19998879
SIC: 2834 Pharmaceutical Preparations